Moderna said it has released the first batch of mRNA-1273, the company’s vaccine against the novel coronavirus, for human use.
- Vials of mRNA-1273 have been shipped to the National Institute of Allergy and Infectious Diseases to be used in the planned Phase 1 study in the U.S.
To view the source of this information click
To contact the reporter on this story:
To contact the editor responsible for this story:
© 2020 Bloomberg L.P. All rights reserved. Used with permission.